{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:39:59Z","timestamp":1792687199228,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Wellcome Trust of Great Britain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14077-w","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:06:53Z","timestamp":1784970413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasmodium falciparum histidine rich protein 2 plasma concentrations from uncomplicated and severe malaria patients estimated by rapid test band intensity"],"prefix":"10.1186","volume":"26","author":[{"given":"Achaporn","family":"Yipsirimetee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chorpaka","family":"Tangjaroenpoonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patpannee","family":"Khanthagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amornrat","family":"Promsongsil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noppadon","family":"Tangpukdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borimas","family":"Hanboonkunupakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesinee","family":"Chotivanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"14077_CR1","unstructured":"Organization WH. World malaria report 2024: addressing inequity in the global malaria response. Geneva; 2024 Dec 11."},{"issue":"2","key":"14077_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pt.2019.12.004","volume":"36","author":"KE Poti","year":"2020","unstructured":"Poti KE, Sullivan DJ, Dondorp AM, Woodrow CJ. HRP2: transforming malaria diagnosis, but with caveats. Trends Parasitol. 2020;36(2):112\u201326.","journal-title":"Trends Parasitol"},{"key":"14077_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2471\/B09145","volume-title":"WHO Guideline for Malaria","author":"WH Organization","year":"2024","unstructured":"Organization WH. WHO Guideline for Malaria. Switzerland: Geneva; 2024 Nov 30."},{"issue":"7","key":"14077_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.trstmh.2004.11.014","volume":"99","author":"V Desakorn","year":"2005","unstructured":"Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, et al. Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005;99(7):517\u201324.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"14077_CR5","doi-asserted-by":"crossref","unstructured":"Hendriksen ICE, Mwanga-Amumpaire J, Von Seidlein L, Mtove G, White LJ, Olaosebikan R, et al. Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma Pf HRP2 measurement. PLoS Med. 2012; 2012;9(8):e1001297.","DOI":"10.1371\/journal.pmed.1001297"},{"issue":"8","key":"14077_CR6","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1371\/journal.pmed.0020204","volume":"2","author":"AM Dondorp","year":"2005","unstructured":"Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005;2(8):e204.","journal-title":"PLoS Med"},{"issue":"3","key":"14077_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/infdis\/jit176","volume":"208","author":"LL Fox","year":"2013","unstructured":"Fox LL, Taylor TE, Pensulo P, Liomba A, Mpakiza A, Varela A, et al. Histidine-rich protein 2 plasma levels predict progression to cerebral malaria in Malawian children with Plasmodium falciparum infection. J Infect Dis. 2013;208(3):500\u20133.","journal-title":"J Infect Dis"},{"issue":"5","key":"14077_CR8","doi-asserted-by":"publisher","first-page":"e35985","DOI":"10.1371\/journal.pone.0035985","volume":"7","author":"MP Rubach","year":"2012","unstructured":"Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, et al. Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS ONE. 2012;7(5):e35985.","journal-title":"PLoS ONE"},{"issue":"654","key":"14077_CR9","doi-asserted-by":"publisher","first-page":"eabn5040","DOI":"10.1126\/scitranslmed.abn5040","volume":"14","author":"JA Watson","year":"2022","unstructured":"Watson JA, Uyoga S, Wanjiku P, Makale J, Nyutu GM, Mturi N, et al. Improving the diagnosis of severe malaria in African children using platelet counts and plasma Pf HRP2 concentrations. Sci Transl Med. 2022;14(654):eabn5040.","journal-title":"Sci Transl Med"},{"key":"14077_CR10","unstructured":"Abbott. NxTek\u2122 Eliminate Malaria Pf: Abbott; [Available from: https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/nxtek-eliminate-malaria-pf.html]."},{"issue":"9753","key":"14077_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647\u201357.","journal-title":"Lancet"},{"issue":"10233","key":"14077_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","volume":"395","author":"RW van Der Pluijm","year":"2020","unstructured":"van Der Pluijm RW, Tripura R, Hoglund RM, Phyo AP, Lek D, Ul Islam A, et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2020;395(10233):1345\u201360.","journal-title":"Lancet"},{"issue":"4","key":"14077_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0035-9203(93)90028-O","volume":"87","author":"K Silamut","year":"1993","unstructured":"Silamut K, White NJ. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1993;87(4):436\u201343.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"14077_CR14","unstructured":"Organization WH. WHO Guideline for Malaria. Geneva, Switzerland; 2023 Oct 16."},{"key":"14077_CR15","volume-title":"WHO Lot testing programme for malaria rapid diagnostic tests (RDTs), 2007\u20132022","author":"WH Organization","year":"2023","unstructured":"Organization WH. WHO Lot testing programme for malaria rapid diagnostic tests (RDTs), 2007\u20132022. Switzerland: Geneva; 2023."},{"issue":"4","key":"14077_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.pcl.2017.03.004","volume":"64","author":"LM Cohee","year":"2017","unstructured":"Cohee LM, Laufer MK. Malaria in Children. Pediatr Clin North Am. 2017;64(4):851\u201366.","journal-title":"Pediatr Clin North Am"},{"issue":"9066","key":"14077_CR17","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S0140-6736(97)02038-2","volume":"349","author":"RW Snow","year":"1997","unstructured":"Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349(9066):1650\u20134.","journal-title":"Lancet"},{"issue":"7476","key":"14077_CR18","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.38251.658229.55","volume":"329","author":"H Reyburn","year":"2004","unstructured":"Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004;329(7476):1212.","journal-title":"BMJ"},{"issue":"1","key":"14077_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12936-022-04301-8","volume":"21","author":"NJ White","year":"2022","unstructured":"White NJ. Severe malaria. Malar J. 2022;21(1):284.","journal-title":"Malar J"},{"key":"14077_CR20","doi-asserted-by":"crossref","unstructured":"Watson JA, Ndila CM, Uyoga S, Macharia A, Nyutu G, Mohammed S, et al. Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision. Elife. 2021;10.","DOI":"10.7554\/eLife.69698"},{"key":"14077_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1741-7015-12-31","volume":"12","author":"J Church","year":"2014","unstructured":"Church J, Maitland K. Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review. BMC Med. 2014;12:31.","journal-title":"BMC Med"},{"issue":"4","key":"14077_CR22","doi-asserted-by":"publisher","first-page":"e0122139","DOI":"10.1371\/journal.pone.0122139","volume":"10","author":"MV Nielsen","year":"2015","unstructured":"Nielsen MV, Amemasor S, Agyekum A, Loag W, Marks F, Sarpong N, et al. Clinical indicators for bacterial co-infection in Ghanaian children with P. falciparum infection. PLoS ONE. 2015;10(4):e0122139.","journal-title":"PLoS ONE"},{"issue":"9","key":"14077_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/qjmed\/hch093","volume":"97","author":"JA Evans","year":"2004","unstructured":"Evans JA, Adusei A, Timmann C, May J, Mack D, Agbenyega T, et al. High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM. 2004;97(9):591\u20137.","journal-title":"QJM"},{"key":"14077_CR24","unstructured":"World Health O. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2\/3 gene deletions. World Health Organization; 2017."},{"issue":"1","key":"14077_CR25","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1038\/s41598-022-09878-3","volume":"12","author":"RD Kaaya","year":"2022","unstructured":"Kaaya RD, Kavishe RA, Tenu FF, Matowo JJ, Mosha FW, Drakeley C, et al. Deletions of the Plasmodium falciparum histidine-rich protein 2\/3 genes are common in field isolates from north-eastern Tanzania. Sci Rep. 2022;12(1):5802.","journal-title":"Sci Rep"},{"issue":"1","key":"14077_CR26","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.1038\/s41598-024-58455-3","volume":"14","author":"E Rogier","year":"2024","unstructured":"Rogier E, Battle N, Bakari C, Seth MD, Nace D, Herman C, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021. Sci Rep. 2024;14(1):8158.","journal-title":"Sci Rep"},{"key":"14077_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1475-2875-11-276","volume":"11","author":"T Ramutton","year":"2012","unstructured":"Ramutton T, Hendriksen IC, Mwanga-Amumpaire J, Mtove G, Olaosebikan R, Tshefu AK, et al. Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria. Malar J. 2012;11:276.","journal-title":"Malar J"},{"issue":"1","key":"14077_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12936-018-2268-7","volume":"17","author":"S Das","year":"2018","unstructured":"Das S, Peck RB, Barney R, Jang IK, Kahn M, Zhu M, et al. Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples. Malar J. 2018;17(1):118.","journal-title":"Malar J"},{"issue":"1","key":"14077_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12936-016-1529-6","volume":"15","author":"F Grandesso","year":"2016","unstructured":"Grandesso F, Nabasumba C, Nyehangane D, Page A-L, Bastard M, De Smet M, et al. Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings. Malar J. 2016;15(1):496.","journal-title":"Malar J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14077-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:03:21Z","timestamp":1792685001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14077-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14077"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14077-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For AQUAMAT study, the patients who tested positive for\n                      P. falciparum\n                      by rapid diagnostic test and met the criteria for severe malaria, or their guardians provided written inform consent prior to enrollment. The same procedure was applied to patients with uncomplicated malaria from TRAC II study. The study was conducted in accordance with the ethical standards of the World Medical Association Declaration of Helsinki, and approved by the Oxford Tropical Research Ethics Committee, University of Oxford (approval no. 034\u2009\u2212\u200902), and the Central Research Ethics Committee, Thailand (approval no. 014\/2015). Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1857"}}